One approach has utilized the GVAX vaccine, which is composed of irradiated pancreatic cancer cells that have been engineered to secrete granulocyte-macrophage colony-stimulating factor (GM-CSF) in order to stimulate immune responses [193]. This evidence concerns the gene CSF2 and familial pancreatic carcinoma.